What does CUSIP 69366J200 represent in this 13F holders report?

CUSIP 69366J200 is the security identifier for PTCT - PTC THERAPEUTICS, INC. - Common Stock used to aggregate holder disclosures.

How many institutions held PTCT - PTC THERAPEUTICS, INC. - Common Stock in Q2 2019?

173 institutional investors reported PTCT - PTC THERAPEUTICS, INC. - Common Stock for Q2 2019. Use the holders table for investor-level position and value details.

PTC THERAPEUTICS, INC. - Common Stock (PTCT)

CUSIP: 69366J200

Q2 2019 13F Holders as of 30 Jun 2019

Type / Class: Equity / Common Stock
Shares outstanding: 80,855,533
Total 13F shares: 58,378,537
Share change: +286,713
Total reported value: $2,626,676,199
Put/Call ratio: 76%
Price per share: $45.00
Number of holders: 173
Value change: +$33,782,408
Number of buys: 95
Number of sells: 80

Quarterly Holders Quick Answers

What is CUSIP 69366J200?
CUSIP 69366J200 identifies PTCT - PTC THERAPEUTICS, INC. - Common Stock in SEC institutional holdings data.

Need full ownership history?
Open the full security ownership history page.

Next holder-history checks

These links keep the next click tied to holder verification, nearby quarters, or outside-13F ownership context.

Back to full security ownership history for the broader multi-quarter picture.
Latest 13F filings for newly reported positions across managers.
Latest Schedule 13D/13G reports for ownership changes outside the 13F cadence.
SEC investors directory for manager drilldown.

Explore More Reporting Periods

Jump to adjacent filing periods for faster comparison and easier crawl discovery.

Newer quarter: Q3 2019
Previous quarter: Q1 2019

Recent filing periods for CUSIP 69366J200:

Q1 2026 Q4 2025 Q3 2025 Q2 2025 Q1 2025 Q4 2024 Q3 2024 Q2 2024

Top shareholders of PTCT - PTC THERAPEUTICS, INC. - Common Stock (13F + 13D/G + 3/4/5)

Grouped by holder across the latest SEC ownership disclosures. Ownership % is shown only when it is directly reported or safely comparable across share classes.

Methodology: rows are grouped by holder and ranked by the holder's primary source value. — indicates unavailable or non-comparable values; "mixed-class rows" means the latest filing spans non-comparable classes.

Holder	Source	Role / Reporting	Ownership %	Shares	Holdings Value	12M Net Δ	As of	Details
VANGUARD GROUP INC	13F	Company	6.1%	4,968,189	$187,002,000	—	31 Mar 2019	13F
BlackRock Finance, Inc.	13F	Company	5.1%	4,107,898	$154,621,000	—	31 Mar 2019	13F
FRANKLIN RESOURCES INC	13F	Company	4.6%	3,744,376	$140,923,000	—	31 Mar 2019	13F
PRICE T ROWE ASSOCIATES INC /MD/	13F	Company	4.4%	3,524,542	$132,664,000	—	31 Mar 2019	13F
Point72 Asset Management, L.P.	13F	Company	3.6%	2,905,393	$109,359,000	—	31 Mar 2019	13F
RTW INVESTMENTS, LP	13F	Company	3.1%	2,514,271	$94,637,000	—	31 Mar 2019	13F
STATE STREET CORP	13F	Company	3.1%	2,500,926	$94,135,000	—	31 Mar 2019	13F
FMR LLC	13F	Company	3%	2,436,735	$91,719,000	—	31 Mar 2019	13F
SCOPIA CAPITAL MANAGEMENT LP	13F	Company	2.6%	2,106,190	$79,277,000	—	31 Mar 2019	13F
CITADEL ADVISORS LLC	13F	Company	2.6%	2,092,195	$78,750,000	—	31 Mar 2019	13F
GREAT POINT PARTNERS LLC	13F	Company	2.2%	1,814,260	$68,289,000	—	31 Mar 2019	13F
ORBIMED ADVISORS LLC	13F	Company	1.9%	1,519,700	$57,202,000	—	31 Mar 2019	13F
JANUS HENDERSON GROUP PLC	13F	Company	1.8%	1,418,479	$53,392,000	—	31 Mar 2019	13F
DEUTSCHE BANK AG\	13F	Company	1.4%	1,092,077	$41,104,000	—	31 Mar 2019	13F
PFM Health Sciences, LP	13F	Company	1.3%	1,086,776	$40,906,000	—	31 Mar 2019	13F
Boxer Capital, LLC	13F	Company	1.2%	1,000,000	$37,640,000	—	31 Mar 2019	13F
WELLINGTON MANAGEMENT GROUP LLP	13F	Company	1.1%	913,936	$34,400,000	—	31 Mar 2019	13F
RENAISSANCE TECHNOLOGIES LLC	13F	Company	1.1%	907,300	$34,151,000	—	31 Mar 2019	13F
D. E. Shaw & Co., Inc.	13F	Company	1.1%	882,636	$33,223,000	—	31 Mar 2019	13F
FARALLON CAPITAL MANAGEMENT LLC	13F	Company	0.87%	700,000	$26,348,000	—	31 Mar 2019	13F
GEODE CAPITAL MANAGEMENT, LLC	13F	Company	0.84%	681,348	$25,645,000	—	31 Mar 2019	13F
NORTHERN TRUST CORP	13F	Company	0.83%	669,778	$25,211,000	—	31 Mar 2019	13F
Marshall Wace North America L.P.	13F	Company	0.82%	662,587	$24,940,000	—	31 Mar 2019	13F
GOLDMAN SACHS GROUP INC	13F	Company	0.76%	614,027	$23,112,000	—	31 Mar 2019	13F
Spark Investment Management LLC	13F	Company	0.7%	566,000	$21,304,000	—	31 Mar 2019	13F
MILLENNIUM MANAGEMENT LLC	13F	Company	0.67%	538,001	$20,250,000	—	31 Mar 2019	13F
Elk Creek Partners, LLC	13F	Company	0.58%	467,537	$17,598,000	—	31 Mar 2019	13F
SECTORAL ASSET MANAGEMENT INC	13F	Company	0.57%	463,137	$17,432,000	—	31 Mar 2019	13F
S.c.a. Candriam	13F	Individual	0.57%	462,523	$17,410,000	—	31 Mar 2019	13F
ARMISTICE CAPITAL, LLC	13F	Company	0.49%	400,000	$15,056,000	—	31 Mar 2019	13F
PICTET ASSET MANAGEMENT LTD	13F	Company	0.49%	396,476	$14,923,000	—	31 Mar 2019	13F
FRONTIER CAPITAL MANAGEMENT CO LLC	13F	Company	0.46%	370,183	$13,934,000	—	31 Mar 2019	13F
BNP Paribas Asset Management Holding S.A.	13F	Company	0.45%	365,674	$13,764,000	—	31 Mar 2019	13F
CHARLES SCHWAB INVESTMENT MANAGEMENT INC	13F	Company	0.44%	357,431	$13,454,000	—	31 Mar 2019	13F
UBS AM, a distinct business unit of UBS ASSET MANAGEMENT AMERICAS LLC	13F	Company	0.38%	307,100	$11,559,245	—	31 Mar 2019	13F
TEACHERS ADVISORS, LLC	13F	Company	0.37%	302,917	$11,402,000	—	31 Mar 2019	13F
Bank of New York Mellon Corp	13F	Company	0.37%	301,704	$11,356,000	—	31 Mar 2019	13F
EMERALD ADVISERS, LLC	13F	Company	0.37%	299,431	$11,271,000	—	31 Mar 2019	13F
Atom Investors LP	13F	Company	0.37%	298,451	$11,234,000	—	31 Mar 2019	13F
CITIGROUP INC	13F	Company	0.35%	283,073	$10,655,000	—	31 Mar 2019	13F
BANK OF AMERICA CORP /DE/	13F	Company	0.34%	275,545	$10,371,000	—	31 Mar 2019	13F
EMERALD MUTUAL FUND ADVISERS TRUST	13F	Company	0.34%	274,712	$10,340,000	—	31 Mar 2019	13F
Invesco Ltd.	13F	Company	0.31%	252,079	$9,488,000	—	31 Mar 2019	13F
AQR CAPITAL MANAGEMENT LLC	13F	Company	0.3%	242,628	$9,133,000	—	31 Mar 2019	13F
INTERNATIONAL BIOTECHNOLOGY TRUST PLC	13F	Company	0.3%	240,493	$9,050,000	—	31 Mar 2019	13F
PRUDENTIAL FINANCIAL INC	13F	Company	0.29%	237,611	$8,943,000	—	31 Mar 2019	13F
DEERFIELD MANAGEMENT COMPANY, L.P.	13F	Company	0.29%	237,000	$8,921,000	—	31 Mar 2019	13F
SPHERA FUNDS MANAGEMENT LTD.	13F	Company	0.27%	220,500	$8,300,000	—	31 Mar 2019	13F
TIAA CREF INVESTMENT MANAGEMENT LLC	13F	Company	0.27%	217,807	$8,198,000	—	31 Mar 2019	13F
Opaleye Management Inc.	13F	Company	0.26%	213,800	$8,047,000	—	31 Mar 2019	13F

Institutional Holders of PTC THERAPEUTICS, INC. - Common Stock (PTCT) as of Q2 2019

As of 30 Jun 2019, PTC THERAPEUTICS, INC. - Common Stock (PTCT) was held by 173 institutional shareholders that filed Form 13F with the SEC. Together, they reported ownership of 58,378,537 shares. The largest 10 holders included VANGUARD GROUP INC, BlackRock Inc., FRANKLIN RESOURCES INC, PRICE T ROWE ASSOCIATES INC /MD/, RTW INVESTMENTS, LP, Point72 Asset Management, L.P., FMR LLC, STATE STREET CORP, ORBIMED ADVISORS LLC, and GREAT POINT PARTNERS LLC. This page lists 173 institutional shareholders reporting positions in this security for the Q2 2019 filing period.

Investor	Option	Weight %	Change %	Value $	* Price	Shares	Share Change	Activity	Report Period

Compare Q2 2019 vs Q1 2019 Across Filers

Q1 2019 holders

169

Q2 2019 holders

173

Holder diff

Investor	Q1 2019 Shares	Q2 2019 Shares	Share Diff	Share Chg %	Q1 2019 Value $	Q2 2019 Value $	Value Diff $	Value Chg %

Trend: ostatnie 8 kwartałów (+ wybrane okresy porównania).

Quarterly Holders Trend

Quarterly Value Trend

Quarterly Shares Trend

* Reported Price is the price of the security as of the portfolio date. This value is significant in that it is the last known price at which the security was still held.
An asterisk sign (*) next to the price indicates that the price is likely invalid.